• Contract Development and Manufacturing Organization Capabilities (CDMO) Questionnaire Form

  • Terms and Conditions of Use

    PLEASE READ THESE TERMS AND CONDITIONS CAREFULLY BEFORE ACCESSING THIS RESOURCE.
  • By accessing this page and the information it contains, you acknowledge that you have read, understood, and agree to be bound by these Terms and Conditions of Use. If you do not agree to these terms, do not proceed to use this resource.

    Restricted Access

    This resource is exclusively available to members of the International Society for Stem Cell Research (“ISSCR”). By proceeding, you confirm that you are an ISSCR member with authorized access.

    Purpose and Scope of the Resource

    ISSCR provides this resource as a listing of Contract Development and Manufacturing Organizations (“CDMO”) solely for informational purposes. The purpose is to support ISSCR members in identifying potential partners. The inclusion of any CDMO in this list does not constitute an endorsement, recommendation, or guarantee of any kind by ISSCR.

    Content Submitted by CDMOs

    The content displayed for each CDMO has been populated solely by the respective CDMO via a questionnaire provided by ISSCR. ISSCR does not verify, validate, fact-check, or review the submitted information for accuracy or completeness. The resource is made available “as is,” and ISSCR disclaims all responsibility for the contents of each CDMO entry.

    No Endorsement or Affiliation

    The appearance of any organization on this list does not imply that ISSCR endorses, supports, certifies, or recommends that organization. ISSCR does not evaluate or vet CDMOs and makes no representation as to the quality or suitability of any organization for any specific use or purpose.

    Limitation of Liability

    YOU AGREE THAT YOUR USE OF THIS RESOURCE AND ANY INFORMATION CONTAINED THEREIN IS AT YOUR OWN RISK. ISSCR EXPRESSLY DISCLAIMS ALL LIABILITY FOR DAMAGES OF ANY KIND ARISING OUT OF OR RELATING TO THE USE OF THIS RESOURCE, INCLUDING BUT NOT LIMITED TO ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES.

    ISSCR SHALL NOT BE HELD LIABLE FOR ANY ACTIONS TAKEN OR NOT TAKEN BASED ON THE CONTENT PROVIDED BY THE CDMOs OR ANY DECISIONS MADE IN RELIANCE ON THE INFORMATION POSTED.

    Disclaimer of Warranties

    ISSCR MAKES NO WARRANTIES OR REPRESENTATIONS, EXPRESS OR IMPLIED, AS TO THE ACCURACY, COMPLETENESS, OR RELIABILITY OF ANY INFORMATION MADE AVAILABLE THROUGH THIS RESOURCE. TO THE FULLEST EXTENT PERMITTED UNDER APPLICABLE LAW, ISSCR DISCLAIMS ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT.

    Modifications to the Terms and Resource

    ISSCR reserves the right to revise these Terms and Conditions at any time and to modify or discontinue, temporarily or permanently, this resource with or without notice. Continued use of the resource following any changes constitutes your acceptance of those changes.

    Acceptance of Terms

    Access to this resource is conditional upon your acceptance of these Terms and Conditions.

  • Instructions

    This questionnaire has 3 pages. Please ensure all mandatory fields are completed on each page before clicking 'Next.' After submission, you will receive a copy of your completed form.
  • Demographic

    This information is private. Submitter information will not be displayed on the ISSCR website. Only the company name, company country or region, and company website will be shown.
  • Geographic region of the company*
  • Indicate your company's broad capabilities*
  • CDMO Questions

  • 2.a. If Yes or In Progress, have you manufactured hPSC Master Cell Banks starting from: (select all that apply)*
  • 0/4000
  • 8. Do you have in-house process development capabilities?*
  • 9. What scale of manufacture are you able to provide for adherent and/or suspension culture for hPSC Master Cell Banks?*
  • 10. What scale of manufacture are you able to provide for adherent and/or suspension culture for hPSC-derived drug substance or drug product?*
  • 11. Please provide the following information about manufactured hPSC Master Cell Bank lot(s) in your facility (range of lot size):

  • 11.a. number of vials*
  • 11.b. volume per vial*
  • 12. What are the final format options you provide for hPSC-derived drug substance or drug product?*
  • 12.a. If vials selected:*
  • 12.b. If bags selected:*
  • 13. Regarding fill and finish, what capabilities does your facility have?*
  • Should be Empty: